Literature DB >> 10627413

Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats.

E Taubøll1, J I Isojärvi, H F Harbo, A J Pakarinen, L Gjerstad.   

Abstract

Long-term valproate treatment is associated with polycystic ovaries and endocrine disorders in women with epilepsy. The mechanisms responsible for these effects are unknown, but both the epilepsy itself and the drug per se may be of importance. The aim of this study was to investigate possible effects of the drug on gonadal structure and function in animals with no epileptic disorders. Three groups, each of 15 female Wistar rats, were fed perorally with a valproate mixture (50 mg / kg or 200 mg / kg) or control solution once daily for 90 days, giving mean valproate concentrations within the normal human range. A significant, 20% increase in ovary weight was found in both low- (P = 0.027) and high- (P < 0.001) dose animals together with a significantly increased number of ovarian follicular cysts. Mean serum testosterone concentration was significantly reduced in both low- and high-dose animals. There was a non-significant trend towards reduced estrogen levels, while progesterone levels were unchanged. Even if the hormonal changes are somewhat different from those in humans, the findings demonstrate that changes in gonadal structure and endocrine function also occur in intact animals indicating a drug-specific effect. Our findings encourages further studies using animal models to elucidate possible mechanisms involved in the endocrine side-effects of antiepileptic drugs. Copyright 1999 BEA Trading Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10627413     DOI: 10.1053/seiz.1999.0342

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  9 in total

Review 1.  [Lamotrigine in women with epilepsy. Review of present data].

Authors:  B Schmitz
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

Review 2.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

Review 3.  Polycystic ovary syndrome and epilepsy: a review of the evidence.

Authors:  Roberta Meo; Leonilda Bilo
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 4.  Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

Authors:  J Bauer; J I T Isojärvi; A G Herzog; M Reuber; D Polson; E Taubøll; P Genton; H van der Ven; B Roesing; G J Luef; C A Galimberti; J van Parys; D Flügel; A Bergmann; C E Elger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

5.  Valproic acid alters GnRH-GABA interactions in cycling female rats.

Authors:  Dinesh Lakhanpal; Gurcharan Kaur
Journal:  Cell Mol Neurobiol       Date:  2007-09-07       Impact factor: 5.046

6.  Seizures and reproductive function: insights from female rats with epilepsy.

Authors:  Helen E Scharfman; Michelle Kim; Tana M Hintz; Neil J MacLusky
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

7.  Association of polycystic ovaries with the use of valproic Acid in jordanian epileptic patients.

Authors:  S Otoom; M Nusier; M Hasan; H Hadidi; R Samawi; A M Younes; M Darweesh; N R Boulatova
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

8.  [The use of lamotrigine in female patients].

Authors:  B Schmitz; L Bergmann
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

9.  The anti-epileptic drug valproic acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro.

Authors:  Claire Glister; Leanne Satchell; Anthony E Michael; Andrew B Bicknell; Philip G Knight
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.